Items Tagged ‘Florida News Release’
February 16th, 2015 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — Cancer researchers at Mayo Clinic’s campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) — a lethal tumor with no effective therapies. The molecule also seems to play a role in a wide range of cancers.
In an online issue of The Journal of Clinical Endocrinology and Metabolism, they identify Stearoyl-CoA desaturase 1 (SCD1) as an oncogenic enzyme that when inhibited and paired with another targeted drug effectively shuts down ATC cell growth and induces cell death.
February 3rd, 2015 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — Precision medicine is getting a jump-start from a new national initiative announced in President Obama's State of the Union message. One Georgia family has already experienced its benefits: genomic testing called whole exome sequencing helped Mayo Clinic neurologist Zbigniew Wszolek, M.D., solve a medical mystery that had left a boy with painful, jerking spasms that at times prevented him from walking or talking. Dr. Wszolek describes the case in a newly published article in the medical journal Mayo Clinic Proceedings.
As a toddler, Dustin Bennett could not keep his balance, and as he grew older, the rigid, jerking spasms mysteriously appeared and disappeared. Over time, he also developed learning disabilities.
Dustin’s adoptive mother, Linda Bennett, took him to several doctors to find the cause of his movement problems, but years of tests, medications and hospital stays came up empty for the Pearson, Georgia, family.
“I wasn’t willing to give up, because I felt there had to be an answer somewhere,” Linda says.
Journalists: Broadcast quality video is available in the downloads.
Tags: Biorepositories program, Dr. Alexander Parker, Dr. Gianrico Farrugia, Dr Zbigniew Wszolek, episodic ataxia type 1, Florida News Release, Individualized Medicine, Matthew Clark PhD, Mayo Clinic Biobank, Mayo Clinic Proceedings, Medical Research, neurology, News Release, precision medicine, whole exome sequencing
January 28th, 2015 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — Mayo Clinic’s campus in Jacksonville, Florida, has received a $5.75 million gift from the Harry T. Mangurian Jr. Foundation in Fort Lauderdale, Florida, to advance the study of Lewy body dementia, a deadly disease that causes a progressive decline in mental and physical abilities. The new Mayo program is one of a few in the world dedicated to finding answers and treatments for the disease.
The gift establishes the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program and builds on the foundation’s previous support of Mayo research to advance awareness and understanding of Lewy body dementia. It also helps support the brain bank on Mayo’s Florida campus, which includes about 1,000 donated organs of deceased patients confirmed to have had Lewy body dementia.
MEDIA CONTACT: Kevin Punsky, Mayo Clinic Public Affairs,
Journalists: Sound bites with Dr. Dickson are available in the downloads.
January 11th, 2015 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — A study of more than 2,000 patients by researchers at Mayo Clinic’s campus in Jacksonville, Florida, has dispelled the myth that cancer biopsies cause cancer to spread. In the Jan. 9 online issue of Gut, they show that patients who received a biopsy had a better outcome and longer survival than patients who did not have a biopsy.
The researchers studied pancreatic cancer, but the findings likely apply to other cancers because diagnostic technique used in this study — fine needle aspiration — is commonly used across tumor types, says the study’s senior investigator and gastroenterologist Michael Wallace, M.D., M.P.H., professor of medicine.
Fine needle aspiration is a minimally invasive technique that uses a thin and hollow needle to extract a few cells from a tumor mass. A long-held belief by a number of patients and even some physicians has been that a biopsy can cause some cancer cells to spread.
While there have been a few case reports that suggest this can happen — but very rarely — there is no need for patients to be concerned about biopsies, says Dr. Wallace.
“This study shows that physicians and patients should feel reassured that a biopsy is very safe,” he says. “We do millions of biopsies of cancer a year in the U.S., but one or two case studies have led to this common myth that biopsies spread cancer.” Read the rest of this entry »
January 5th, 2015 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — Mayo Clinic has named John Presutti, D.O., as chief executive officer of Mayo Clinic Health System in Waycross (Georgia), effective March 2, 2015. Dr. Presutti succeeds Kenneth Calamia, M.D., who will retire from Mayo Clinic at the end of 2015.
“Dr. Presutti is a wonderfully gifted and proven physician leader,” says Gianrico Farrugia, M.D., chief executive officer of Mayo Clinic’s campus in Jacksonville, Florida. “He brings energy and passion to his work and is committed to building upon Dr. Calamia’s successful leadership and involvement in the Waycross community.”
Dr. Presutti has been with Mayo Clinic since 1997. He currently is chair of the Division of Regional Medicine in the Department of Family Medicine at Mayo Clinic’s campus in Jacksonville, Florida. He also serves as medical director for Contracting and Payer Relations and is a member of the executive operations teams in Florida and Waycross. As a family practice physician, Dr. Presutti has dedicated his career to the health and well-being of his patients and the training and education of other family medicine physicians. Read the rest of this entry »
December 23rd, 2014 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — Three researchers at Mayo Clinic’s campus in Jacksonville, Florida have received $1.2 million from the newly funded Florida Health Ed and Ethel Moore Alzheimer’s Research Program to study various aspects of Alzheimer’s disease. The program was created earlier this year to improve the health of Floridians by researching prevention and diagnosis of Alzheimer’s disease.
December 16th, 2014 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — It may not be necessary for experienced gastroenterologists to send polyps they remove from a patient’s colon to a pathologist for examination, according to a large study conducted by physician researchers at the Jacksonville campus of Mayo Clinic.
Their 522-patient study, published in the December issue of Gastrointestinal Endoscopy, found that physicians correctly evaluated whether a polyp was precancerous or benign using high-definition optical lenses during a colonoscopy. Their assessment was 96 or 97 percent accurate — depending on which of two generations of scopes was used — compared with a standard pathological evaluation of the polyps.
The Mayo Clinic researchers conclude that the pathological polyp examination now required by national practice guidelines may not be necessary — an advance they say could result in substantial cost savings for the patient and the health care system, as well as more rapid information and recommendations for follow-up for the patient. Read the rest of this entry »
December 12th, 2014 · Leave a Comment
By Kevin Punsky
JACKSONVILLE, Fla. — Mayo Clinic has appointed Christina Zorn, J.D., as chief administrative officer of its campus in Jacksonville, Fla., and vice chair of Administration, Mayo Clinic.
She will serve as administrative partner to Gianrico Farrugia, M.D., incoming vice president of Mayo Clinic and chief executive officer of the Jacksonville campus, as previously announced. Zorn assumes her new role on Jan. 1.
“Christina Zorn has significant experience at Mayo Clinic as well as excellent insight into the strengths of Mayo Clinic’s Florida staff and the unique challenges of the local and regional market,” says Dr. Farrugia. “I look forward to working with Christina as we continue the excellent efforts underway in delivering outstanding care to our patients, advancing research and educating the next generation of providers in Florida and throughout the Southeast.”
Zorn has been with Mayo Clinic since 2002. She began her career at Mayo Clinic as a legal counsel and now serves as the chair of the Florida division of the Legal Department. In addition, Zorn has served as an administrator for the Department of Ophthalmology in Florida and for several key initiatives.
She succeeds Robert Brigham, who has served as chief administrative officer in Florida since 2005. Brigham will retire from Mayo Clinic at the end of 2014. Zorn will work closely with Brigham to ensure a smooth leadership transition.
MEDIA CONTACT: Kevin Punsky, Mayo Clinic Public Affairs, 904-953-0746,firstname.lastname@example.org Read the rest of this entry »
December 8th, 2014 · Leave a Comment
By Paul Scotti
JACKSONVILLE, Fla. — A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with chemotherapy for HER2-positive breast cancer. But that marker — the quantity of tumor-infiltrating lymphocytes (S-TILs) in a biopsy — appears irrelevant when trastuzumab is used.
Tags: 2014 San Antonio Breast Cancer Symposium, Breast Cancer, Edith Perez, Florida News Release, HER2+ breast cancer, M.D., Mayo Clinic Cancer Center, Mayo Clinic in Florida, News Release, trastuzumab Herceptin, triple negative breast cancer, cancer
November 14th, 2014 · Leave a Comment
JACKSONVILLE, Fla. — The Mayo Clinic Board of Trustees welcomed Mary Sue Coleman, Ph.D., as a new public member at its quarterly meeting today.
Dr. Coleman is president emeritus of the University of Michigan, (U-M) an institution she led for 12 years before retiring in July 2014. Time magazine named her one of the nation’s “10 best college presidents,” and the American Council on Education honored her with its Lifetime Achievement Award. She previously was president of the University of Iowa.
As University of Michigan president, Dr. Coleman unveiled several major initiatives designed to impact on future generations of students, the intellectual life of the campus, and society at large. The initiatives focused on the interdisciplinary richness of the U-M, student residential life, the economic vitality of the state and nation, global engagement and the value of innovation and creativity. President Obama chose Dr. Coleman to help launch the Advanced Manufacturing Partnership, a national effort bringing together industry, universities and the federal government.
Click here for a bio of Dr. Mary Sue Coleman.
MEDIA CONTACT: Karl Oestreich, Mayo Clinic Public Affairs, 507-284-5005, email@example.com.